2002年～2004年长江流域6城市157家医院心血管系统药物利用分析

Analysis on Cardiovascular Drugs Used in 157 Hospitals of 6 Cities in the Yangtze River Valley during the Period of 2002～2004

目的:评价2002年～2004年长江流域6城市157家医院心血管系统药物应用状况及趋势。方法:利用金额排序法和用药频度排序法,对长江流域6城市157家医院的心血管系统用药进行统计、分析。结果:2004年6城市心血管系统用药总金额达13.6亿元,较2002年增长58.8%,其中抗心绞痛药及血管扩张药、抗血栓药、抗高血压药3个亚类用量3年平均占整个心血管用药的84.1%。在金额排序和用药频度排序前列中,主要包括钙拮抗药、血管紧张素转化酶抑制药、硝酸酯、β受体阻滞药和中药制剂类产品。结论:用药依从性好、不良反应发生率低、疗效确切、日均费用低的药物已成为临床医师治疗心血管疾病的首选。

OBJECTIVE： To evaluate the current situation and the trend of cardiovascular drugs used in 6 cities in the Yangtze river valley between 2002 and 2004. METHODS：Consumption of cardiovascular drugs used in 157 hospitals of 6 cities in the Yangtze river valley were analyzed by the way of sum and DDDs ranking. RESULTS： The total annual cost of the cardiovascular drugs used in 6 cities was 13.6 billion yuan in 2004, increasing by 58.8%, as compared with that in 2002. The total average consumption of anti-anginal and vasodilating agents, antithrombotic agents and antihypertensives accounted for 84.1% of the total cost in 3 years.CCB, ACEI, Nitrate esters,β-blockers and Chinese medicines dominated in the ranking of sum and DDDs. CONCLUSION： Right medicines with higher patient compliance rates, lower ADR occurrence, more certain therapeutic effect and economical daily cost have become the preferable choices for clinical physicians.